Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions – Marketscreener.com

Lakewood, Colorado, US - Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, software and services for blood component collection, therapeutic apheresis and cellular technologies, today announces it has signed a new collaborative agreement with GenCure, a subsidiary of BioBridge Global, to extend and unify cell and gene therapy manufacturing solutions.

The latest agreement between Terumo Blood and Cell Technologies (Terumo) and BioBridge Global follows a series of long-running activities between the organizations for more than 20 years, including with a number of BioBridge Global's subsidiaries. It is anticipated that this latest agreement will extend into a broader collaboration with the full array of BioBridge Global's subsidiaries. Both parties have signed the new agreement to further combine technologies and expertise to cater to the demand across the cell and gene therapy (CGT) industry for smart systems that are automated and closed. These smart-systems allow for real-time response and refinement to the living therapies being produced inside the systems.

This collaboration will initially utilize expertise from Terumo and GenCure to establish a reference manufacturing center for BioBridge Global. This includes both organizations jointly developing core process and manufacturing operations. The reference site will enable GenCure to deliver a full solution for cell and gene therapy developers. It will be based at GenCure's process development and cGMP manufacturing facility at the VelocityTX campus in San Antonio, Texas, US.

Terumo will contribute a variety of products from its portfolio to allow in-plant optimization of processes and user feedback, along with investment in new products and process utilization. GenCure will leverage its highly developed expertise in Terumo Blood and Cell Technologies' cell collection, cell and gene therapy manufacturing and fill-finish equipment. This will significantly enhance its portfolio for developers requiring process optimization and manufacturing support.

The collaboration is scheduled to last three years and is in two phases. The first phase will enable Terumo to select from its portfolio of automated and closed-cell and gene therapy manufacturing devices and share the range of services offered at GenCure. This combination will help solve the critical industry gaps in manufacturing capacity and operational expertise. The second phase will allow GenCure and other BioBridge Global subsidiaries to use Terumo's data management solutions and value-added services to seamlessly transition between clinical and manufacturing sites by enabling chain-of-custody/identity and consistency of leukapheresis products.

Terumo selected GenCure as a key collaborator that has access under the BioBridge Global umbrella to all of the services needed for cell and gene therapy manufacturing that originates from blood products. These include donor recruitment, cell collections, cell selection and manufacturing facilities and biological testing services. The collaboration allows Terumo to link blood and cell collections with cell and gene therapy manufacturing. There is currently a critical lack of skills and knowledge bridging these areas.

"Despite the rapid evolution of the cell and gene therapy sector, critical challenges such as management between collection, manufacturing sites and logistics still remain unresolved. For over 20 years, Terumo has been working with BioBridge to provide safe, high-quality blood products," said Delara Motlagh, General Manager, Cell Therapy Technologies, Terumo Blood and Cell Technologies. "We are now combining our product portfolios, expertise and management to provide a vital link between cell collection sites and cell and gene therapy manufacturing sites, while addressing capacity and ensuring GMP production. This will provide a route to deliver cutting-edge cell and gene therapies through pursuing new standards of collection and manufacturing, including quality, consistency and demonstrated scalability."

Martin Landon, Chief Executive Officer of BioBridge Global said: "Across the cell and gene therapy sector, collaborations are now proving vital to the rapid development of solutions to a number of key challenges. Our donor-to-patient solutions, which include cell collection, manufacturing and testing, require the best technologies and expertise available in the market. Working with an innovator like Terumo Blood and Cell Technologies will allow us to provide a leading-edge end-to-end solution for cell and gene therapy manufacturing that will be vital to deliver advanced therapies to patients."

ENDS

About Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers.

Terumo Blood and Cell Technologies' customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 130 countries across the globe. We have more than 750 granted patents, with more than 150 additionally pending.

We have global headquarters in Lakewood, Colo., US., along with five regional headquarters, seven manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology.

About GenCure

GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, provides process development and optimization expertise and cGMP manufacturing services for cell and cell-based advanced therapies companies as the anchor tenant for the VelocityTX landmark biotech innovation corridor complex. Working with its sister subsidiaries, GenCure understands and provides support for donor-to-patient services with a foundation in the critical elements related to clinical practice standards, access to source materials, testing services, research and development, and clinical research support. Learn more at GenCure.org.

About BioBridge Global

BioBridge Global (BBG) is a San Antonio, Texas-based 501(c)(3) nonprofit advanced therapies enterprise that offers diverse services through its subsidiaries - South Texas Blood & Tissue, QualTex Laboratories, GenCure and The Blood and Tissue Center Foundation. BBG provides products and services, donor recruitment and sample collection for a wide range of blood and tissue types, processing and manufacturing support, and testing of both donor and finished products for clients in the United States and worldwide. BBG is committed to saving and enhancing lives through the healing power of human cells and tissue. It enables advances in the field of regenerative medicine by providing access to human cells and tissue, testing services and biomanufacturing and clinical trials support. Learn more at BioBridgeGlobal.org.

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE

Visit link:
Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions - Marketscreener.com

Precision Cancer Therapies Market Size And Forecast | Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira,…

New Jersey, United States Precision Cancer Therapies MarketReport 2022-2029, has been prepared based on an in-depth market analysis with inputs from industry experts. The Precision Cancer Therapies market study sheds light on the important growth dynamics expected to prevail across the assessment period 2022-2029. The study offers statistics of key segments across prominent geographies, along with a detailed mapping of the global competitive landscape. Moreover, The market report tracks the global sales of Precision Cancer Therapies in 25+ high growth markets, along with analyzing the impact COVID-19 has had on the current industry and the Precision Cancer Therapies sector in particular.

Key Drivers & Barriers:

High-impact rendering factors and drivers have been studied in the Precision Cancer Therapies market report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks in the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)@https://www.verifiedmarketreports.com/download-sample/?rid=477671

(Use Company eMail ID to Get Higher Priority)

In its latest report, Verified Market Reports offers an exhaustive overview of the Precision Cancer Therapies market with a focus on key dynamics, including drivers, restraints, opportunities, trends, and detailed information about the Precision Cancer Therapies market structure. Precision Cancer Therapies market sales across the world will rise with the increasing adoption of R&D activities and advanced technology. With the outbreak of COVID-19, companies have become heavily reliant on digital platforms for survival.

Prominent Key players of the Precision Cancer Therapies market survey report:

Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca, Aveo Pharmaceuticals

Key Segments Covered in Precision Cancer Therapies Market Industry Analysis By Types, Applications, and Regions:

Precision Cancer Therapies Market Types Outlook (Revenue, USD Million, 2017 2029)

Hormone Therapy Immunotherapies Targeted Therapy Monoclonal Antibody Therapy Gene Therapy

Precision Cancer Therapies Market Applications Outlook (Revenue, USD Million, 2017 2029)

Hospitals Diagnostic Centers Oncology Clinics Research Institutes

For More Information or Query or Customization Before Buying, Visit @https://www.verifiedmarketreports.com/product/precision-cancer-therapies-market-size-and-forecast/

Precision Cancer Therapies Market Report Scope

Regional Analysis of the Precision Cancer Therapies Market:

The Precision Cancer Therapies Market research report details the ongoing market trends, development outlines, and several research methodologies. It illustrates the key factors that directly manipulate the Market, for instance, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes within the product profiles could result in huge disruptions to the above-mentioned factors.

North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What insights does the Precision Cancer Therapies Market report provide to the readers?

Precision Cancer Therapies fragmentation on the basis of product type, end-use, and region Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape Collaborations, R&D projects, acquisitions, and product launches of each Precision Cancer Therapies player Various regulations imposed by the governments on the consumption of Precision Cancer Therapies in detail Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the Precision Cancer Therapies

Get a Discount On The Purchase Of This Report@https://www.verifiedmarketreports.com/ask-for-discount/?rid=477671

Visualize Precision Cancer Therapies Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

Visualize Precision Cancer Therapies Market using VMI @https://www.verifiedmarketresearch.com/vmintelligence/

Top Trending Reports

Global Proctoscopes Market Size And Forecast

Global Precision Cancer Therapies Market Size And Forecast

Global Predictive Biomarkers Market Size And Forecast

Global Prenatal Testing Market Size And Forecast

Global Pressure Guidewire Market Size And Forecast

Global Programmable Infusion Pumps and Catheters Market Size And Forecast

Global Progressive Multifocal Leukoencephalopathy Treatment Market Size And Forecast

Global Prostate Cancer Screening Market Size And Forecast

Global Proteasome Inhibitors Market Size And Forecast

Global Protection Films for Medical Devices Market Size And Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies.

We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Our research spans over a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080 UK: +44 (753)-715-0008 APAC: +61 (488)-85-9400 US Toll-Free: +1 (800)-782-1768

Email: [emailprotected]

Website: https://www.verifiedmarketreports.com/

Read more from the original source:
Precision Cancer Therapies Market Size And Forecast | Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira,...

Chronic Granulomatous Disease Treatment Market New Report 2027: Research Methodology Focuses On Exploring Major Factors Influencing The Industry…

Chronic Granulomatous Disease Treatment Market is expected to grow at a CAGR of 8.46% .

Decisive Markets Insights Global Chronic Granulomatous Disease Treatment Market research report on Global market growth (Status and Outlook) 2020-2026 provides detailed information and an overview of the critical factors required to make a sound business decision. Global Market Sizing: A Comprehensive Analysis of Global, Regional, and Country Markets features a detailed examination of market factors, including competitive analysis, market size, market share, opportunities, and sales analysis, along with value chain analysis, and value chain optimization. There are nine market segments within the report, each addressing applications, types, regional outlooks, market demands, latest trends, and industry shares and revenue by manufacturers, company profiles, and growth forecasts.

Kindly click on the link below if you intend to make a direct purchase @:-https://www.decisivemarketsinsights.com/chronic-granulomatous-disease-treatment-market/80351883/buy-now

Chronic Granulomatous Disease Treatment Market Segmentation- By Type : Medication, Bone Marrow Transplant, Gene Therapy, Others By Application : Hospitals, Homecare, Specialty Clinics, Others By Key Players : Clinigen Group plc, Orchard Therapeutics plc, Gnthon, Horizon Therapeutics plc, ViroMed. Co.Ltd, Bellicum Pharmaceuticals, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Lonza, GlaxoSmithKline plc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Merck KGaA, Smith & Nephew, JCR Pharmaceuticals Co.Ltd, MaxCyte, Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Antares Pharma

This report is wide in concept and content right from Chronic Granulomatous Disease Treatment market The Global Market Report is important because: By providing an overall view of the global market, the Chronic Granulomatous Disease Treatment Market report provides significant insights into the global market. Market segments are categorized into sub-segments and geography. To provide a more detailed analysis and understanding of the market, the key segments have been further categorized into sub-segments. This Chronic Granulomatous Disease Treatment Market report covers a comprehensive analysis of market trends and factors impacting the global industry. According to the report, market concentration rate, price trends, growth opportunities, and raw material expenditure graph are used to summarize the market.The report covers several vendors operating in the global market. There are also complete statistics for numbers, divisions, revenue, and shares, and an analysis of current trends, opportunities, and industry news.

In order to make a pre-order inquiry, kindly click on the link below:-https://www.decisivemarketsinsights.com/chronic-granulomatous-disease-treatment-market/80351883/pre-order-enquiry

Answers to the following questions about the market are discussed in the report: Which companies dominate the global market? In what ways will a variety of factors affect market growth? In the global market, what mergers and acquisitions, product launches, and collaborations have taken place recently? How would you classify the market? How do major players formulate their strategies? Where will the fastest growth occur in the application segment? In what way is the market expected to grow? What is the most likely regional market to emerge as the winner in the next few years? Which growth strategies are employed by the companies to maintain their position on the global market?

HEART AND SOUL OF THE Chronic Granulomatous Disease Treatment Market REPORT: The report includes CAGR, BCG Matrix, Break-Even Analysis, PORTER 5 Forces and PESTEL Analysis. This report includes points that influence the customers expectation of new product and service, sources of desired product and service expectation, sources of adequate product and service expectation, sources of both desired and predicted product and service, what decision a top executive take if customers expectation are unrealistic. Strategic Brand and Product management are also highlighted in the report. Different Public Relation activities of global leaders during the crisis is also mentioned in the report.

To inquire about the discount, kindly fill the form by clicking on the link below:-https://www.decisivemarketsinsights.com/chronic-granulomatous-disease-treatment-market/80351883/request-discount

The reports objectives are as follows: A projection of sales volume and value for key market segments is required. In addition to defining, describing, and analysing the sales volumes, values, market shares, and competitive landscape of key companies. A new product launch, an acquisition, or an expansion in the market will be assessed based on the competitive environment. By identifying its various sub-segments, you can gain an understanding of the structure of the market. Detailed information will be provided regarding the key factors influencing the market growth (growth potential, opportunities, challenges, and risks). To study and analyse the market size, key regions, products, end-user and forecast to 2026.

To avail Sample Copy of report, visit @ https://www.decisivemarketsinsights.com/chronic-granulomatous-disease-treatment-market/80351883/request-sample

Key questions addressed by Decisive Markets Insights in Chronic Granulomatous Disease Treatment report: (1) What will be the impact of the rigid governmental policies on the global Chronic Granulomatous Disease Treatment market over the forecasted period of 2020-2027? (2) What are key strategies adopted by the global Chronic Granulomatous Disease Treatment market leaders to enhance their business growth? (3) What are the different methods to effectively analyze the overall growth of the Chronic Granulomatous Disease Treatment market? (4) What will be the scenario of the global market over the forecasted period of 2020-2027 along with its CAGR?

Decisive Markets Insights Sunil Kumar Sales Head Email [emailprotected] Website-https://www.decisivemarketsinsights.com/ US +18317045538 UK +441256636046 Address:- 26, Broadway, Suite 934, New York , 10004

Social Links: Twitter @ https://twitter.com/decisivemarket

Linkedin @ https://www.linkedin.com/company/decisive-markets-insights

Here is the original post:
Chronic Granulomatous Disease Treatment Market New Report 2027: Research Methodology Focuses On Exploring Major Factors Influencing The Industry...

Cystinuria Treatment Market indication by Industry Dynamics, Regional breakdown and Forecast 2022- 2027 The Daily Vale – The Daily Vale

New York, United States: The Cystinuria Treatment Market research report crafted by DECISIVE MARKETS INSIGHTS delineates a list of the latest upgrades of the different business plans including several units and collaborations embraced by the significant global market leaders. It elucidates a crystal-clear scenario regarding the adoption of upgraded technologies for expansion of the customer base as well as enlarging the current competitive global market. The most possible CAGR percentage over the forecasted period of 2020-2027 has been thoroughly incorporated.

Kindly click on the link below if you intend to make a direct purchase @:-https://www.decisivemarketsinsights.com/cystinuria-treatment-market/22080545/buy-now

A comprehensive summary of the global market with an in-depth insight on its crucial aspects have been elucidated such as the total volume of sales and marketing, the overall quantity of production and consumption, gross margins, import, export, competitive landscape analysis, in-depth price analysis, diversified licensing strategies, graphical representations vendor landscapes, key investment areas, vital parameters for adequate market evaluation, Modern Market Regulation, market size, etc. The Cystinuria Treatment Market report delineates a comprehensive evaluation of the deadly COVID-19 pandemic and its adverse impacts on the current global market as well as assesses the potential market results over the forecasted period of 2020-2027.

Quicky avail limited copies of the Sample of the Cystinuria Treatment Market report: visit @ https://www.decisivemarketsinsights.com/cystinuria-treatment-market/22080545/request-sample

Cystinuria Treatment Market Segmentation- By Type : Gene Therapy, Copper Injection Therapy By Application : Hospitals, Homecare, Specialty Clinics and Others By Key Players : Retrophin, Inc, Mission Pharmacal Company, Revive Therapeutics Ltd, Teva Pharmaceutical Industries Ltd, Amerigen Pharmaceuticals Limited, Mylan N.V., Bausch Health, Zhejiang Huahai Pharmaceutical Co., Ltd, WOCKHARDT

Why should you buy this report?

Inculcates a wide range of applications as well as supplies valuable information regarding the essential variables that facilitate the enlargement of the market range of numerous vital applications as well as the earning share of every application. Elucidates crucial information regarding the variety of opportunities for global market expansion over the forecasted period of 2020-2027. The report contains a strong analysis methodology with an in-depth and well-formed SWOT, BCG, and PESTEL analysis. A broad explanation of the overall market behavior and functionality has been inculcated thoroughly. The global Cystinuria Treatment Market behaviour is necessary to predict the overall market growth. For that, it is compulsory to have in-depth knowledge about Modern Market Segmentation as well as its segments and sub segments. Different key investment areas for global market growth and different parameters of market evaluation are elucidated in detail.

Request for discount if you intend to purchase the report immediately: https://www.decisivemarketsinsights.com/cystinuria-treatment-market/22080545/request-discount

Key questions addressed by Decisive Markets Insights in Cystinuria Treatment Market report:

(1) What will be the various strategies adopted by the global market leaders for effective market growth over the forecasted period of 2020-2027? (2) What will be the entire scenario of the global market in the upcoming span of 7 years along with its CAGR? (3) What are the biggest challenges that a business can face and what are the different opinions of the industrial experts to overcome those daunting challenges? (4) What is the variety of opportunities for global market growth post-COVID-19 pandemic?

In order to make a pre- order inquiry kindly click on the link below: https://www.decisivemarketsinsights.com/cystinuria-treatment-market/22080545/pre-order-enquiry

Kindly contact us and our expert will get back to you within 30 minutes:

Decisive Markets Insights Sunil Kumar Sales Head Email [emailprotected] Website-https://www.decisivemarketsinsights.com/ US +18317045538 UK +441256636046 Address:- 26, Broadway, Suite 934, New York , 10004

Social Links: Twitter-https://twitter.com/decisivemarket

Linkedin-https://www.linkedin.com/company/decisive-markets-insights

Go here to read the rest:
Cystinuria Treatment Market indication by Industry Dynamics, Regional breakdown and Forecast 2022- 2027 The Daily Vale - The Daily Vale

Adrenoleukodystrophy Treatment Market 2021 Regional and Global Analysis with Forecast Data and Leading The Daily Vale – The Daily Vale

The report formulated at DECISIVE MARKETS INSIGHTS includes a broad analysis of the recent technological development and innovation which encapsulates the key principle of market growth, consumer behavior along with examples that are relevant in the global context. This Adrenoleukodystrophy Treatment Market report is wide in concept right from market dynamics such as drivers, restraints, opportunities, and constraints which can be a game-changer for the companies forecasted from 2020 to 2027. This report is well- organized that provides comprehensive coverage of both consumer behavior as well as practical application. This focus on branding and related real-life market examples are a key distinguishing feature that makes this report unique from others and relevant for marketers. This report helps the companies to adopt the different strategies to propel their market growth and make the important decision of their crucial investment.

Kindly click on the link below if you intend to make a direct purchase @:-https://decisivemarketsinsights.com/adrenoleukodystrophy-treatment-market/88689638/buy-now

This report also takes into consideration the ongoing impact of the global pandemic, challenges & threats faced by Adrenoleukodystrophy Treatment Market globally This report also provides what are the different approaches taken by global leaders to change crisis into opportunities. The pandemic not only affects the global supply chain but also change the existing market and key players. This report provides insightful data with the help of which company can take an important decision and enhance their performance forecasted throughout 2020 to 2027. The report helps the different companies to know the strategies implemented by global leaders and what are the recent product or services, and business areas they start operating.

To avail Sample Copy of report, visit @ https://decisivemarketsinsights.com/adrenoleukodystrophy-treatment-market/88689638/request-sample

Adrenoleukodystrophy Treatment Market Segmentation- By Type : Medication, Gene Therapy, Bone Marrow Transplantation and Others By Application : Hospitals, Homecare, Specialty Clinics, Others By Key Players : bluebird bio, Inc., Orpheris, Inc., MedDay Pharmaceuticals, MINORYX THERAPEUTICS SL, Pfizer Inc., Amgen Inc., AstraZeneca, Abbott, agtc, ReceptoPharm, Inc., The Myelin Project, SOM Biotech SL, Viking Therapeutics, Nutra Pharma Corporation, Genetix Biotech Asia Pvt. Ltd., Magenta Therapeutics, NeuroVia, Inc., Novartis AG, CELGENE CORPORATION, Jazz Pharmaceuticals, Inc., Sanofi

KEY INSIGHT FROM THE REPORT: This report provides the data regarding the market share, sales growth, acquisition rate, acquisition cost, the objective of customer activity measurement, average Inter purchase Time, Retention and Defection Rate, Survival Rate, CLV, P(Active). This report includes a popular customer-based value matrix-like size of the wallet, the share of category requirement, the share of wallet and Transition Matrix.

In order to make a pre-order inquiry, kindly click on the link below:-https://decisivemarketsinsights.com/adrenoleukodystrophy-treatment-market/88689638/pre-order-enquiry

This report also provides information related to important merger and acquisition, collaboration, partnership, and different CSR which help the business to enhance performance over the forecasted period. The report also provides the Reverse positioning, breakaway positioning, and Stealth position of different market leaders and when each one is best suited This report contains the various data in the form of bar diagram, pie chart, histogram and heat map which is easy to visualized and interpret. This report also contains a well-structure SWOT ANALYSIS, PESTLE, CAGR, CLV, BCG, and perceptual mapping which acts as a catalyst for business growth.

To inquire about the discount, kindly fill the form by clicking on the link below:-https://decisivemarketsinsights.com/adrenoleukodystrophy-treatment-market/88689638/request-discount

Kindly contact us and our expert will get back to you within 30 minutes:

Decisive Markets Insights Sunil Kumar Sales Head Email [emailprotected] US +18317045538 UK +441256636046 Address:- 26, Broadway, Suite 934, New York , 10004

Go here to read the rest:
Adrenoleukodystrophy Treatment Market 2021 Regional and Global Analysis with Forecast Data and Leading The Daily Vale - The Daily Vale

Leigh Syndrome Treatment Market Research Study, Future Prospects and Growth Drivers to 2029 | Top Key Vendors GKS, Brother Enterprises, Huazhong The…

Overview of Global Leigh Syndrome Treatment Market:

An international Leigh Syndrome Treatment Market report is an excellent report that makes it possible to the Healthcare industry to take strategic decisions and achieve growth objectives. Such a great report has been prepared by a team of enthusiastic analysts, skilled researchers and experienced forecasters who work meticulously for the same. This report will act as a sure shot solution to the challenges and problems faced by Healthcare industry. The scope of Leigh Syndrome Treatment Market research report involves industry research, customer insights, market sizing and forecast, competitive analysis, market entry strategy, pricing trends, sustainability trends, innovation trends, technology evolution, and distribution channel assessment.

The Global Leigh Syndrome Treatment Market is expected to gain market growth in the forecast period of 2022 to 2029.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-leigh-syndrome-treatment-market .

Leigh Syndrome Treatment Market report is a defined study of the Healthcare industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. This global market report contains all the company profiles of the major players and brands. The market drivers and restraints have also been explained using SWOT analysis. The report exhibits important product developments and tracks recent acquisitions, mergers and research in the Healthcare industry by the key players. An influential Leigh Syndrome Treatment Market research report not only gives an advantage to grow business but also helps outshine the competition.

According to the market report analysis, Leigh Syndrome is a rare, genetic neurodegenerative disease which rarely occurs in teenagers or adults. Symptoms typically progress quickly. Early symptoms could include poor sucking ability, loss of head and motor skills, loss of appetite, vomiting and seizures. Symptoms may include weakness and lack of muscle tone, spasticity, movement disorders, cerebellar ataxia, and peripheral neuropathy, as the condition progresses.

Some of most important key factors driving the growth of the Global Leigh Syndrome Treatment Market are rising prevalence of treatment procedures such as gene therapy and RNA therapeutics.

Global Leigh Syndrome Treatment Market Segmentation:

Based on the Type, the Global Leigh Syndrome Treatment Market is segmented into mitochondrial DNA-associated leigh syndrome, and nuclear gene-encoded leigh syndrome.

Based on the Treatment, the leigh syndrome treatment market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), laboratory test, and others.

Based on the Route of Administration, the leigh syndrome treatment market is segmented into oral, parenteral, and others.

Based on the End-Users, the leigh syndrome treatment market is segmented into hospitals, specialty clinics and others.

Regional analysis, Americas is expected to hold the largest share of the leigh syndrome treatment market for treating leigh syndrome due to the increasing mitochondrial disorders in the U.S. Leigh syndrome is much more prevalent in other groups, according to the National Center for Advancing Translational Science (NIH).

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-leigh-syndrome-treatment-market

Global Key Vendors:

GlaxoSmithKline Plc

Brother Enterprises

Huazhong

Zhejiang Tianxin

Stryker Corporation

Zimmer Biomet Holdings, Inc

Wright Medical Technology, Inc

Integra LifeSciences Holdings Corporation

Key questions answered in the report:

What will the market growth rate of Leigh Syndrome Treatment market in 2029? What are the key factors driving the global Leigh Syndrome Treatment market? What are sales, revenue, and price analysis of top manufacturers of Leigh Syndrome Treatment market? Who are the distributors, traders and dealers of Leigh Syndrome Treatment market? Who are the key manufacturers in Leigh Syndrome Treatment market space? What are the Leigh Syndrome Treatment market opportunities and threats faced by the vendors in the global Leigh Syndrome Treatment market? What are sales, revenue, and price analysis by types and applications of Leigh Syndrome Treatment market? What are sales, revenue, and price analysis by regions of Leigh Syndrome Treatment market? What are the market opportunities, market risk and market overview of the Leigh Syndrome Treatment market?

For More Insights Get FREE Detailed TOC of Global Leigh Syndrome Treatment Market Report 2022 @ https://www.databridgemarketresearch.com/toc/?dbmr=global-leigh-syndrome-treatment-market .

Major Highlights of TOC: Global Leigh Syndrome Treatment Market

1 Global Leigh Syndrome Treatment Market Overview

2 Global Leigh Syndrome Treatment Market Competitions by Manufacturers

3 Global Leigh Syndrome Treatment Capacity, Production, Revenue (Value) by Region (2022-2029

4 Global Leigh Syndrome Treatment Supply (Production), Consumption, Export, Import by Region (2022-2029)

5 Global Leigh Syndrome Treatment Production, Revenue (Value), Price Trend by Type

6 Global Leigh Syndrome Treatment Market Analysis by Application

7 Global Leigh Syndrome Treatment Manufacturers Profiles/Analysis

8 Leigh Syndrome Treatment Manufacturing Cost Analysis

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

11 Market Effect Factors Analysis

12 Global Leigh Syndrome Treatment Market Forecast (2022-2029)

13 Research Findings and Conclusion

14 Appendix

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [emailprotected]

See the original post:
Leigh Syndrome Treatment Market Research Study, Future Prospects and Growth Drivers to 2029 | Top Key Vendors GKS, Brother Enterprises, Huazhong The...

StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA – Digital Journal

First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of blood

TORONTO, ON and RICHMOND, VA / ACCESSWIRE / May 25, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) (StageZero or the Company), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced that it has partnered with DiagnoseAtHome (DAH) to make the Companys multi-cancer blood test, Aristotle, available to DiagnoseAtHomes patients in Canada and the USA. Built on StageZeros proprietary mRNA gene expression technology platform, Aristotle is a next-generation test which simultaneously screens for multiple cancers from a single sample of blood.

DiagnoseAtHome offers accessible at-home health and lab testing solutions, allowing businesses, organizations, and healthcare providers to offer safe, accurate and discreet lab testing to patients as an alternative to in-person laboratory visits. Powered by a proprietary technology platform, DAH partners with telehealth organizations, assisted living, long-term care facilities, corporations, self-insured employers, healthcare providers, and clinics.

Our partnership with DiagnoseAtHome allows greater access to early cancer screening for their many clients and broadens the availability of Aristotle in Canada and the USA, said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. Growing our patient base and expanding the availability of our early cancer test is a key pillar in our Growth Strategy. We look forward to working with DiagnoseAtHome and their patients and clients.

Our partnership with StageZero Life Sciences furthers our mission to provide accessible cutting edge diagnostic solutions to patients and providers at scale said Dr Ian Plener, founder of DiagnoseAtHome. By onboarding Aristotle to the DAH platform, we are better able to provide our patients and providers with a novel approach to early cancer screening. Growing our laboratory network will further enhance the breadth of curated laboratory solutions available to our growing patient and provider base. We look forward to working with the entire StageZero Life Sciences team.

Aristotle is the first-ever mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Aristotle test works by interrogating mRNA from a sample of whole blood and detecting gene expression profiles indicative of specific cancers. Aristotle screens for the molecular signatures associated with multiple, individual cancers, including breast, ovarian, endometrial, colorectal, liver, stomach, prostate, and others.

To learn more, please visit https://www.stagezerolifesciences.com/aristotle-test.html.

About StageZero Life Sciences, Ltd.

StageZero Life Sciences, Ltd. is a vertically integrated healthcare company dedicated to improving the early detection and management of cancer and other chronic diseases through next-generation diagnostics and unique telehealth programs that provide clinical interventions to assist patients who currently have cancer (COC Protocol) as well as help patients reduce the risk of developing late-stage disease (AVRT).

The Companys next generation test, Aristotle, is the first ever mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Companys patented technology platform, the Sentinel Principle. This underlying technology has been validated in more than 9,000 patients and used by more than 100,000 patients in North America.

The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Developed by scientists and oncologists, the COC Protocol is intended for adjunctive administration alongside standard-of-care cancer therapy. It is an individualized therapeutic approach which seeks to simultaneously target multiple metabolic cancer pathways. The aim is to restrict cancer cell energy supply and use, which may make it more difficult overall for cancer cells to survive, grow, and adapt to changing conditions in the body. As a result, such cells can potentially become more vulnerable to attack from cell-killing therapies such as radiotherapy and chemotherapy. The patented COC Protocol incorporates a multifaceted approach, supported by peer-reviewed scientific studies, which highlight the potential of certain treatments to target the specific energy requirements of cancer cells, impacting their ability to grow and multiply.

AVRT is a physician-Led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Our program includes: a comprehensive online health evaluation; blood tests to measure markers of inflammation and metabolism; an in-depth initial physician consultation; regular physician follow-up appointments and interval screening.

Aristotle, as well as additional cancer diagnostics (ColonSentry, and the Prostate Health Index) are processed at the Companys clinical laboratory, StageZero Life Sciences, Inc., a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, the Company is also leveraging its specialty in polymerase chain reaction (PCR) testing to provide COVID-19 PCR testing (swab and saliva) and Antibody Testing (blood analysis).

StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.

About DiagnoseAtHome:

DiagnoseAtHome is a multichannel health technology company specializing in at-home health and laboratory testing solutions, allowing businesses, organizations and healthcare providers to offer safe, accurate and discreet lab testing to patients as an alternative to in-person laboratory visits. DiagnoseAtHome has partnered with leading virtual care organizations, corporations and healthcare providers to support modern and scalable accessibility to diagnostic testing. Harnessing a leading proprietary technology platform, DAH delivers the most comprehensive, affordable and efficient at-home lab testing platform with the most expansive test menu. DAHs propriety technology platform integrates with a broad network of ISO, CLIA and CAP-certified high complex laboratory partners, providing the most reliable, accurate and expansive at-home laboratory capabilities. DAHs logistics arm has perfected over-the-mail testing, providing best in class medical kitting, stability and results validation. With a focus on research and innovation, the DAH platform will continue to be at the forefront of health tech innovation.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as expects, will and similar expressions, which reflect the Companys current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Companys actual events to differ materially from those projected herein. Investors should consult the Companys ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

Important Safety Information

The Aristotle, and ColonSentry tests were developed, and their performance characteristics determined, by Stage Zero Life Sciences, Inc. They have not been cleared or approved by the U.S. Food and Drug Administration. These tests are performed in a CLIA certified laboratory and are intended for clinical purposes. These tests must be ordered by and used only in consultation with a healthcare provider.

For further information please contact:

Investor Relations

Rebecca Greco 1-855-420-7140 ext. 1838 [emailprotected]

Media Contact Kristin Villiotte SHIFT Communications [emailprotected]

SOURCE: StageZero Life Sciences Ltd

View source version on accesswire.com: https://www.accesswire.com/702700/StageZero-Life-Sciences-Partners-with-DiagnoseAtHome-to-Offer-AristotleR-Multi-Cancer-Blood-Test-in-Canada-and-USA

Read more here:
StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA - Digital Journal

Laser Doppler Blood Flow Measurement Devices Market Size Report with Comprehensive Research and Geographical Segmentation Forecast Report 2022 The…

Global Laser Doppler Blood Flow Measurement Devices Market Report is a great source of information about the Laser Doppler Blood Flow Measurement Devices industry, important facts and figures, expert opinions, and the most recent developments across the globe. Such perfect and comprehensive market report brings into focus primary and secondary drivers, market share, leading segments, possible sales volume, and geographical analysis. The report contains reviews about key players in the market, major collaborations, merger and acquisitions along with trending innovation and business policies. Laser Doppler Blood Flow Measurement Devices business report also provides CAGR value fluctuations during the forecast period of 2022 2029 for the market.

Market Analysis and Size

Laser Doppler Blood Flow Measurement Devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 6407.88 million by 2027 growing with the CAGR of 32.54% in the above-mentioned forecast period. The high success rate of Laser Doppler Blood Flow Measurement Devices along with clinical trial and preclinical trial is gaining popularity among the patient which is leading towards the market.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-laser-doppler-blood-flow-measurement-devices-market

Market research analysis and insights displayed in the winning Laser Doppler Blood Flow Measurement Devices report are very thoughtful for the businesses to make enhanced decisions, to build up better strategies about production, marketing, sales and promotion of a particular product. This market report also takes into consideration several major factors such as revenue, cost, gross and gross margin while analysing market data. Various markets at local, regional and international level are thought of in this Laser Doppler Blood Flow Measurement Devices marketing report. All this helps in extending their reach towards the success. The use of advanced tools and techniques applied for this report makes it the premium in the class. By understanding clients needs precisely, this report merges business and product information for the sustainable growth in the market

Global Laser Doppler Blood Flow Measurement Devices Market Analysis

Increase in funding of research and development in the activities of Laser Doppler Blood Flow Measurement Devices along with rise in prevalence of cancer is likely to accelerate the growth of the Laser Doppler Blood Flow Measurement Devices market in the forecast period of 2020-2027. On the other hand, the favourable government regulations for therapy is further going to boost various opportunities that will lead to the growth of the Laser Doppler Blood Flow Measurement Devices market in the above mentioned forecast period.

High cost involved in gene therapy along with unwanted immune responses wills likely to hamper the growth of the Laser Doppler Blood Flow Measurement Devices market in the above mentioned forecast period.

This Laser Doppler Blood Flow Measurement Devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on Laser Doppler Blood Flow Measurement Devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Key Segmentation:

By Type (Single-channel, Multi-channel)

By Application (Hospitals and Clinics, Diagnostic Centers, Others)

Top Manufacturers of Laser Doppler Blood Flow Measurement Devices Market:

Compumedics Limited

Transonic

Medistim

ADInstruments

Atys Medical

Carolina Home Medical Inc

BIOPAC Systems, Inc

Medtronics

Deltex Medical

.

To Know More Details, Click Here@https://www.databridgemarketresearch.com/reports/global-laser-doppler-blood-flow-measurement-devices-market

Table of Contents

Report Overview

Market Analysis by Types

Product Application Market

Manufacturers Profiles/Analysis

Market Performance for Manufacturers

Regions Market Performance for Manufacturers

Global COVID-19 Impact on Laser Doppler Blood Flow Measurement Devices Market Performance (Sales Point)

Development Trend for Regions 9. Upstream Source, Technology and Cost

Channel Analysis

Consumer Analysis

Laser Doppler Blood Flow Measurement Devices Market Forecast

Conclusion

Read Complete Report Along With TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-laser-doppler-blood-flow-measurement-devices-market

Key questions answered in the report:

Which are the five top players of the Laser Doppler Blood Flow Measurement Devices market?

How will the Laser Doppler Blood Flow Measurement Devices market change in the next forthcoming years?

Which product and application will take a lions share of the Laser Doppler Blood Flow Measurement Devices market and Comprehensive valuation of all prospects?

What are the drivers, restraints constraints, Restraints and Opportunities of the Laser Doppler Blood Flow Measurement Devices market?

Which regional market will show the highest growth?

What will be the CAGR and size of the Laser Doppler Blood Flow Measurement Devices market throughout the forecast period?

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia Pacific

Europe: Germany, the UK, France, and Rest of Europe

North America: The US, Mexico, and Canada

Latin America: Brazil and Rest of Latin America

Middle East & Africa: GCC Countries and Rest of Middle East & Africa

Global Laser Doppler Blood Flow Measurement Devices Market Scope and Market Size

Laser Doppler Blood Flow Measurement Devices market is segmented on the basis of therapy and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on therapy, the Laser Doppler Blood Flow Measurement Devices market is segmented into oncolytic virotherapy, gene induced immunotherapy and gene transfer. The oncolytic virotherapy is further sub-segmented into adenovirus, lentivirus, retro virus, adeno associated virus, herpes simplex virus, alpha virus, vaccinia virus, simian virus and others. The gene induced immunotherapy is further sub-segmented into delivery of cytokines gene and delivery of tumor antigen gene. The gene transfer is further sub-segmented into naked/plasmid vectors, electroporation, sonoporation, magnetofection and gene gun.

Laser Doppler Blood Flow Measurement Devices market has also been segmented based on the end user into hospitals, oncology institutes, biotechnological companies and clinical research laboratories.

Points Highlighted in the Report:

The report includes an overall business forecast that aims to gain valuable insights into the global Laser Doppler Blood Flow Measurement Devices Market.

The main segments have been further classified into sub-segments for a detailed review and a deeper understanding of the industry.

The factors leading to market growth have been listed. The data has been collected from primary and secondary sources and analyzed by professionals in the field.

The study analyses the latest trends and company profiles of the major players in the market.

Go here to see the original:
Laser Doppler Blood Flow Measurement Devices Market Size Report with Comprehensive Research and Geographical Segmentation Forecast Report 2022 The...

Alpha Thalassemia Market Potential Growth, Share, Demand and Analysis of Key Players & Forecasts to 2030 The Daily Vale – The Daily Vale

Global Alpha Thalassemia Market report emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the Alpha Thalassemia Market.

Global Alpha Thalassemia Market research report analyzes top players in the key regions like North America, South America, Middle East and Africa, Asia and Pacific region. It delivers insight and expert analysis into key consumer trends and behavior in market place, In addition to an overview of the market data and key brands. It also provides all data with easily digestible information to guide every businessmans future innovation and move business ahead.

Global Alpha Thalassemia Market Segmentation Analysis:

By Top Key Players

Nvrt lubrd d hrm lrn hrm

By Types

Iron Chelating Drugs Gene Therapy

By Applications

Hospitals Private Clinics

Click the link to get a free Sample Copy of the Report @ https://crediblemarkets.com/sample-request/alpha-thalassemia-market-347525?utm_source=Amruta&utm_medium=SatPR

Alpha Thalassemia Market, By Geography:

The regional analysis of Alpha Thalassemia market is studied for region such as Asia pacific, North America, Europe and Rest of the World. The North America is one of the leading region in the market due to numerous cross industry collaborations taking place between automotive original equipment manufacturers and mobile network operators (MNOs) are taking place for continuous internet connectivity inside a car to enhance the user experience of connected living, while driving. Asia-Pacific region is one of the prominent player in the market owing to large enterprises and SMEs in the region are increasingly adopting Alpha Thalassemia solutions.

Some Points from Table of Content

Global Alpha Thalassemia Market 2022 by Company, Regions, Type and Application, Forecast to 2030

1 Alpha Thalassemia Introduction and Market Overview

2 Industry Chain Analysis

3 Global Alpha Thalassemia Market, by Type

4 Alpha Thalassemia Market, by Application

5 Global Alpha Thalassemia Consumption, Revenue ($) by Region (2018-2022)

6 Global Alpha Thalassemia Production by Top Regions (2018-2022)

7 Global Alpha Thalassemia Consumption by Regions (2018-2022)

8 Competitive Landscape

9 Global Alpha Thalassemia Market Analysis and Forecast by Type and Application

10 Alpha Thalassemia Market Supply and Demand Forecast by Region

11 New Project Feasibility Analysis

12 Expert Interview Record

13 Research Finding and Conclusion

14 Appendix

Direct Purchase this Market Research Report Now @ https://crediblemarkets.com/reports/purchase/alpha-thalassemia-market-347525?license_type=single_user;utm_source=Amruta&utm_medium=SatPR

Reasons to Purchase this Report

About US

Credible Markets is a new-age market research company with a firm grip on the pulse of global markets. Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

The collection of market intelligence reports is regularly updated to offer visitors ready access to the most recent market insights. We provide round-the-clock support to help you repurpose search parameters and thereby avail a complete range of reserved reports. After all, it is all about helping you reach an informed strategic decision about purchasing the right report that caters to all your market research demands.

Contact Us

Credible Markets Analytics

99 Wall Street 2124 New York, NY 10005

Email: [emailprotected]

Read more from the original source:
Alpha Thalassemia Market Potential Growth, Share, Demand and Analysis of Key Players & Forecasts to 2030 The Daily Vale - The Daily Vale

Delayed treatment of Ankylosing Spondylitis can lead to lifelong bone fusion – Times of India

Ankylosing Spondylitis (AS) is an auto-immune disease. It refers to abnormal functioning of the bodys immune system, where the system starts mistakenly attacking the bodys own normal tissues causing inflammation (swelling) of the joints in the spine. If untreated the joints can get permanently damaged and can lead to irreversible bone fusion.

Reducing the disease progression with treatment

Early and correct diagnosis of disease can substantially reduce disease progression and severity. Regular exercise and maintaining healthy weight are essential to complement medical therapy. Modern treatment aims at stopping the disease progression, easing the pain and stiffness, keeping the spine mobile and thus helping the patient towards finding a balanced normal living situation. Ideally, the disease can be managed through a combination of pain relief exercises and disease modifying drugs.

A Rheumatologist is an expert in treating ankylosing spondylitis and must be consulted early in the course of illness. Advanced therapies like biologics used by Rheumatologists help slow down or stop the disease progression altogether. Biologics have been the most significant advancements towards managing the condition, especially for patients who do not respond well to the traditional disease modifying drugs.

Lifestyle changes to curb the pain of the disease

Patients with AS have found a significant amount of relief by adopting a regular routine of physical activities, sports, and stretching exercises. The disease demands movement because it reduces inflammation. Activities like swimming, yoga, light weightlifting etc. can significantly help in marinating mobility.

Taking a professional advice for types of excises is important. Physiotherapy is a very important part of the treatment for Ankylosing Spondylitis. A physiotherapist can put together a programme of exercises that increase your muscle strength and help you maintain mobility in your spine and other joints. Its especially important to exercise your back and neck to avoid them stiffening in a bent position.

Awareness about the disease, its signs and symptoms

Awareness about Ankylosing Spondylitis is relatively less among general population in India. Most people will commonly mistake AS as posture-related back pain. Its important to understand and be aware of the initial signs such as early-morning stiffness in the spine that finds comfort through activity, and excessive pain during the night. Such patients traditionally suffer from an exhilarating pain in their lower back and hip, which gradually leads to spine fusion. The disease manifests at the early ages of 15-35 years, and starts to show itself and grow significantly, if left untreated. The pain can impact patients everyday productivity.

Most, but not all, people with AS carry a gene called HLA-B27. Although people carrying this gene are more likely to develop the disease, it is also found in up to 8% of normal population who have no signs of the condition. Having this gene doesnt mean youll definitely get AS.

Delayed treatment of AS in India

Unfortunately, delayed diagnosis of AS is a globally recognized problem. On an average, Indian studies show a delay of 3-6 years in the diagnosis of AS. Delayed diagnosis and treatment can cause irreversible structural damage which, consequently, can affect patients mobility and quality of life.

Only a small number of patients (>25%) directly visit a rheumatologist for initial assessment of their symptoms of AS.Many patients only reach rheumatology clinics after seeing multiple specialists, which contributes to the long diagnostic delay. Along with the patients not knowing whom to reach out to, the insufficient number of rheumatologists in India, is simultaneously a key reason behind this delay.

Additionally, opting for unregulated alternative therapy also results in a longer delay in reaching to a rheumatologist. Fear of adverse effects of modern medicine is another barrier in the early treatment initiation. Its now become an urgent requirement to find methods of elucidating available information regarding modern medicine in order to address patients concerns and improve their health seeking behaviour.

Facebook Twitter Linkedin Email

Views expressed above are the author's own.

Continue reading here:
Delayed treatment of Ankylosing Spondylitis can lead to lifelong bone fusion - Times of India